APA (7th ed.) Citation

CS, S., Y, W., A, A., H, D., P, C., Q, L., . . . X, W. (2024). Phase I pharmacokinetic, safety, and preliminary efficacy study of tiragolumab in combination with atezolizumab in Chinese patients with advanced solid tumors. Cancer chemotherapy and pharmacology, 94(1), 45. https://doi.org/10.1007/s00280-024-04650-y

Chicago Style (17th ed.) Citation

CS, Shemesh, et al. "Phase I Pharmacokinetic, Safety, and Preliminary Efficacy Study of Tiragolumab in Combination with Atezolizumab in Chinese Patients with Advanced Solid Tumors." Cancer Chemotherapy and Pharmacology 94, no. 1 (2024): 45. https://doi.org/10.1007/s00280-024-04650-y.

MLA (9th ed.) Citation

CS, Shemesh, et al. "Phase I Pharmacokinetic, Safety, and Preliminary Efficacy Study of Tiragolumab in Combination with Atezolizumab in Chinese Patients with Advanced Solid Tumors." Cancer Chemotherapy and Pharmacology, vol. 94, no. 1, 2024, p. 45, https://doi.org/10.1007/s00280-024-04650-y.